December 10, 2018
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
Read More
December 10, 2018
A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)
Read More
X